Discussion of these questions will provide a summary of the current state of knowledge regarding hypothalamic orexin regulation of physical activity during aging and provide a platform on which to develop improved clinical outcomes in age-associated obesity and metabolic syndromes. The gene discussed is HCRT; the disease is obesity due to melanocortin 4 receptor deficiency.